AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2024
Oct 8, 2024
34395_dirs_2024-10-08_13a85591-e0ff-4214-9890-7109ece2e90f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2024-10-04-05:00
Reporting Person: Batchelor Ann-Louise (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-10-04-05:00 | Common Stock | F | 6110 | $0.883 | Disposed | 101566 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 29406 | Indirect |
Footnotes
F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
More from VOLITIONRX LTD
Share Issue/Capital Change
2026
Jun 18
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 2
Capital/Financing Update
2026
May 22
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Proxy Solicitation & Information Statement
2026
May 13